Published • loading... • Updated
Anuh Pharma get prequalification nod from WHO for anti-malarial bulk drug
Summary by Express Pharma
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Anuh Pharma get prequalification nod from WHO for anti-malarial bulk drug
Anuh Pharma has received prequalification approval from World Health Organization (WHO) for anti-malarial active pharmaceutical ingredient (API) Amodiaquine Hydrochloride USP, the company said in its filing with the stock exchanges. Amodiaquine Hydrochloride is an essential medicine listed by the WHO and widely used in combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria, the filing said. This approval further c…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
